Ribavirin for SARS in Children

Clinical Pediatrics

Volumn 43, Issue 2, 2004, Pages 193-196

  Cheng, Wai Tsoi Frankie ^a   Li, Chi Kong ^a   Leung, Ting Fan ^a   Li, Albert Man Chim ^a   Hon, Kam Lun Ellis ^a   Ng, Pak Cheung ^a   Fok, Tai Fai ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; METHYLPREDNISOLONE; PREDNISOLONE; RIBAVIRIN;

ADOLESCENT; ANEMIA; ARTICLE; ASTHENIA; CASE REPORT; CHILD; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPERAMMONEMIA; HYPERURICEMIA; HYPOCALCEMIA; INFANT; MALE; RASH; SARS CORONAVIRUS; SEIZURE; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS IDENTIFICATION;

ADOLESCENT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; CORONAVIRUS; FEMALE; HUMANS; INFANT; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBAVIRIN; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 1542375899     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992280404300211     Document Type: Article

References (9)

1. Drosten C, Günther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348:1967-1976.
2. Poutanen SM, Low DE, Henry B, et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med. 2003;348:1995-2005.
3. So LKY, Lau ACW, Yam LYC, et al. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet. 2003;361:1615-1617.
4. Hon EKL, Leung CW, Cheng WTF, et al. Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet. 2003;361:1701-1703.
5. World Health Organization. Case definitions for surveillance of severe acute respiratory syndrome (SARS). Accessed at: www.who.int/csr/sars/casedefinition/en/.
6. Peiris JSM, Chu CM, Cheng VCC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361:1767-1772.
7. Chang CH, Chen KY, Lai MY, et al. Meta-analysis: ribavirin-induced haemolytic anemia in patients with chronic hepatitis C. Aliment Pharmacol Ther. 2002;16:1623-1632.
8. Li CK, Chan PK, Ling SC, et al. Interferon and ribavirin as frontline treatment for chronic hepatitis C infection in thalassaemia major. Br J Haematol. 2002;117:755-758.
9. Joseph BM, Isabel JK, Patricia AW, et al. Lassa fever: effective therapy with ribavirin. N Engl J Med. 1986;314:20-26.